Alexander H. Schmidt

ORCID: 0000-0003-0979-5914
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • T-cell and B-cell Immunology
  • Hematopoietic Stem Cell Transplantation
  • Immune Cell Function and Interaction
  • Renal Transplantation Outcomes and Treatments
  • Immunotherapy and Immune Responses
  • Blood groups and transfusion
  • Cytomegalovirus and herpesvirus research
  • Acute Myeloid Leukemia Research
  • Organ Donation and Transplantation
  • Immunodeficiency and Autoimmune Disorders
  • Biomedical Ethics and Regulation
  • Organ Transplantation Techniques and Outcomes
  • vaccines and immunoinformatics approaches
  • Transplantation: Methods and Outcomes
  • Reproductive System and Pregnancy
  • Hemoglobinopathies and Related Disorders
  • Prenatal Screening and Diagnostics
  • Glycosylation and Glycoproteins Research
  • Olfactory and Sensory Function Studies
  • Diabetes and associated disorders
  • Acute Lymphoblastic Leukemia research
  • Single-cell and spatial transcriptomics
  • Mesenchymal stem cell research
  • Evolutionary Psychology and Human Behavior
  • COVID-19 Clinical Research Studies

German National Bone Marrow Donor Registry
2014-2025

Deutsche Knochenmarkspenderdatei
2016-2025

Centre for Genomic Regulation
2024

University of Massachusetts Chan Medical School
2020

WHU – Otto Beisheim School of Management
2014

Banc de Sang i Teixits
2010

École Supérieure des Sciences Économiques et Commerciales
2010

CY Cergy Paris Université
2010

Newcastle University
2010

Fondation de France
2010

Abstract Background A close match of the HLA alleles between donor and recipient is an important prerequisite for successful unrelated hematopoietic stem cell transplantation. To increase chances finding donor, registries recruit many hundred thousands volunteers each year. Many with limited resources have had to find a trade-off cost resolution extent typing newly recruited donors in past. Therefore, we taken advantage recent improvements NGS develop workflow low-cost, high-resolution...

10.1186/1471-2164-15-63 article EN cc-by BMC Genomics 2014-01-24
Matthias Stelljes Jan Moritz Middeke Gesine Bug Eva‐Maria Wagner‐Drouet Lutz Müller and 91 more Christoph Schmid Stefan W. Krause Wolfgang Bethge Edgar Jost Uwe Platzbecker Stefan Klein Jörg Schubert Judith Niederland Martin Kaufmann Kerstin Schäfer‐Eckart Markus Schaich Henning Baldauf Friedrich Stölzel Cathleen Petzold Christoph Röllig Nael Alakel Björn Steffen Beate Hauptrock Christoph Schliemann Katja Sockel Fabian Lang Oliver Kriege Judith Schaffrath Christian Reicherts Wolfgang E. Berdel Hubert Serve Gerhard Ehninger Alexander H. Schmidt Martin Bornhäuser Jan‐Henrik Mikesch Johannes Schetelig Nael Alakel Jörn C. Albring Wolfgang E. Berdel Wolfgang Bethge Martin Bornhäuser Gesine Bug Christoph Buhl Simon Call Martina Crysandt Katharina Egger‐Heidrich Eva Eßeling Christoph Faul Georg‐Nikolaus Franke Julia-Annabell Georgi Julia Glück-Wolf Christoph Groth Beate Hauptrock Daniela Heidenreich Snjezana Janjetovic Edgar Jost Martin Kaufmann Thomas Kindler Stefan Klein Stefan W. Krause Sebastian Kreil Theresa Kretschmann Désirée Kunadt Fabian Lang Georg Lenz Sonja Martin Julia Marx Jan-Moritz Middeke Jan‐Henrik Mikesch Lutz Müller Nadine Müller Judith Niederland Stefani Parmentier Kathrin Petzold Uwe Platzbecker Andreas Rank Christian Reicherts Christoph Röllig Wolf Rösler Kerstin Schäfer‐Eckart Judith Schaffrath Markus Schaich Johannes Schetelig Christoph Schliemann Christoph Schmid Dominik Schneidawind Jörg Schubert Hubert Serve Katja Sockel Björn Steffen Matthias Stelljes Raphael Teipel Malte von Bonin Eva Wagner-Drouet Maxi Wass Knut Wendelin

Whether high-dose cytarabine-based salvage chemotherapy, administered to induce complete remission in patients with poor responsive or relapsed acute myeloid leukaemia scheduled for allogeneic haematopoietic stem-cell transplantation (HSCT) after intensive conditioning confers a survival advantage, is unclear. To test chemotherapy before HSCT, aged between 18 and 75 years non-favourable-risk not first induction untreated relapse were randomly assigned 1:1 cytarabine (3 g/m2 intravenously, 1...

10.1016/s2352-3026(24)00065-6 article EN cc-by The Lancet Haematology 2024-04-04

A catalog of common, intermediate and well‐documented (CIWD) HLA‐A, ‐B, ‐C, ‐DRB1, ‐DRB3, ‐DRB4, ‐DRB5, ‐DQB1 ‐DPB1 alleles has been compiled from over 8 million individuals using data 20 unrelated hematopoietic stem cell volunteer donor registries. Individuals are divided into seven geographic/ancestral/ethnic groups summarized for each group the total population. P (two‐field) G assignments one four frequency categories: common (≥1 in 10 000), 100 (≥5 occurrences) or not‐CIWD. Overall 26%...

10.1111/tan.13811 article EN cc-by HLA 2020-01-23

At the DKMS Life Science Lab, Next Generation Sequencing (NGS) has been used for ultra-high-volume high-resolution genotyping of HLA loci last three and a half years. Here, we report on our experiences in HLA, CCR5, ABO, RHD KIR genes using direct amplicon sequencing approach Illumina MiSeq HiSeq 2500 instruments.Between January 2013 June 2016, 2,714,110 samples largely from German, Polish UK-based potential stem cell donors have processed. 98.9% all alleles targeted (HLA-A, -B, -C, -DRB1,...

10.1186/s12864-017-3575-z article EN cc-by BMC Genomics 2017-02-14

Homozygous carriers of CCR5-Δ32, a gene variant CC-type chemokine receptor 5 (CCR5), are highly resistant to infections with human immunodeficiency virus type 1 (HIV-1) and therefore preferred stem cell donors for HIV-infected patients. We analyzed CCR5 typing data 1,333,035 potential hematopoietic enlisted three national DKMS donor centers. Allele genotype frequencies were determined 87 countries origin as self-assessed by the donors. CCR5-Δ32 allele ranged from 16.4% in Norwegian sample 0...

10.1016/j.humimm.2017.10.001 article EN cc-by Human Immunology 2017-10-11

Background A catalogue of common and well‐documented (CWD) human leukocyte antigen (HLA), previously established by the American Society for Histocompatibility Immunogenetics (ASHI), is widely used as indicator typing ambiguities to be resolved in tissue transplantation or checking universality any HLA allele world. However, European population samples, which are characterized a substantial level genetic variation, underrepresented ASHI catalogue. Therefore, Population Genetics Working Group...

10.1111/tan.12956 article EN HLA 2017-01-18

Leprosy, a chronic infectious disease caused by Mycobacterium leprae (M. leprae), was very common in Europe till the 16th century. Here, we perform an ancient DNA study on medieval skeletons from Denmark that show lesions specific for lepromatous leprosy (LL). First, test remains M. to confirm infection status of individuals and assess bacterial diversity. We assemble 10 complete genomes all differ each other. Second, evaluate whether human leukocyte antigen allele DRB1*15:01, strong LL...

10.1038/s41467-018-03857-x article EN cc-by Nature Communications 2018-04-16

The killer-cell immunoglobulin-like receptor (KIR) genes regulate natural killer cell activity, influencing predisposition to immune mediated disease, and affecting hematopoietic stem transplantation outcome. Owing the complexity of KIR locus, with extensive gene copy number variation allelic diversity, high-resolution characterization has so far been applied only relatively small cohorts. Here, we present a comprehensive high-throughput genotyping approach based on next generation...

10.3389/fimmu.2018.02843 article EN cc-by Frontiers in Immunology 2018-12-04

The high‐throughput department of DKMS Life Science Lab encounters novel human leukocyte antigen ( HLA ) alleles on a daily basis. To characterise these alleles, we have developed system to sequence the whole gene from 5′‐ 3′‐ UTR for loci A, B, C, DQB1 and DPB1 submission European Molecular Biology Laboratory – Nucleotide Archive EMBL‐ENA IPD‐IMGT / Database. Our workflow is based dual redundant sequencing strategy. Using shotgun an Illumina MiSeq instrument single molecule real‐time SMRT...

10.1111/tan.13057 article EN cc-by HLA 2017-05-25

Optimizing natural killer (NK) cell alloreactivity could further improve outcome after allogeneic hematopoietic transplantation (alloHCT). The donor’s Killer-cell Immunoglobulin-like Receptor (KIR) genotype may provide important information in this regard. In the past decade, different models have been proposed aiming at maximizing NK activation by activating KIR-ligand interactions or minimizing inhibitory interactions. Alternative classifications intended predicting alloHCT donor...

10.3389/fimmu.2024.1350470 article EN cc-by Frontiers in Immunology 2024-04-02

The characterization of the ABO blood group status is vital for transfusion and solid organ transplantation. Several methods molecular gene, which encodes alleles that give rise to different groups, have been described. However, application those has so far restricted selected samples not applied population-scale analysis. We describe a cost-effective method high-throughput genotyping system by next generation sequencing. Sample specific barcodes sequencing adaptors are introduced during...

10.1186/s12864-016-2687-1 article EN cc-by BMC Genomics 2016-05-20

The risk of acute graft-versus-host disease (GvHD) after hematopoietic stem cell transplantation is increased with donor-recipient HLA-DPB1 allele mismatching. single-nucleotide polymorphism (SNP) rs9277534 within the 3' untranslated region (UTR) correlates allotype expression and serves as a marker for permissive mismatches. Since not routinely typed, we analyzed 32,681 samples mostly European ancestry to investigate if can be reliably imputed from standard DPB1 genotyping. We confirmed...

10.1016/j.humimm.2017.11.001 article EN cc-by Human Immunology 2017-11-07

Mothers are able to identify the body odour (BO) of their own child and prefer this smell above other BOs. It has hence been assumed that infantile BO functions as a chemosignal promoting targeted parental care. We tested hypothesis examined whether children's BOs signal genetic similarity developmental status mothers. In addition, we assessed facilitate inbreeding avoidance (Westermarck effect). cross-sectional design, N = 164 mothers participated with biological children ( 226 children,...

10.1098/rstb.2019.0266 article EN cc-by Philosophical Transactions of the Royal Society B Biological Sciences 2020-04-19

Pathogens and associated outbreaks of infectious disease exert selective pressure on human populations, any changes in allele frequencies that result may be especially evident for genes involved immunity. In this regard, the 1346-1353 Yersinia pestis-caused Black Death pandemic, with continued plague spanning several hundred years, is one most devastating recorded history. To investigate potential impact Y. pestis immunity genes, we extracted DNA from 36 victims buried a mass grave...

10.1093/molbev/msab147 article EN cc-by Molecular Biology and Evolution 2021-05-13

This study explores pregnant women's awareness of cord blood stem cells and their attitude regarding banking options in France, Germany, Italy, Spain, the UK.Questionnaires were distributed six maternities. anonymous self-completed questionnaire included 29 multiple-choice questions based on: 1) sociodemographic factors, 2) access to information about banking, 3) option preferences, 4) donating units (CBUs) research.A total 79% women had little (n = 1620). A 58% heard therapeutic benefits...

10.1111/j.1537-2995.2010.02954.x article EN Transfusion 2010-12-03

Highlights•8/8 and 10/10 donor match rates vary by patient race ethnicity.•Three-year unrelated registry growth resulted in 2% to 4% increase 8/8 rate.•Most searches did not have a matched identified before clarifying typing.•Most patients can find after testing 1to 2 donors, when 1 exists.AbstractThe National Marrow Donor Program's Be The Match Registry® facilitates the worldwide utilization of (URD) grafts for need hematopoietic cell transplantation. In this study, we estimate URD rate...

10.1016/j.bbmt.2014.10.002 article EN cc-by-nc-nd Biology of Blood and Marrow Transplantation 2014-10-13
Coming Soon ...